Pakistan Moves to Regulate Online Medicine Sales
The Drug Regulatory Authority of Pakistan (DRAP) has taken a decisive step to safeguard public health by seeking a ban on the online sale of unregistered medicines. Officials argue that the uncontrolled availability of such products poses serious risks to patients, as these medicines have not undergone proper testing or approval.
DRAP emphasized that only medicines registered under the Drug Act 1976 should be allowed for sale, whether through physical pharmacies or online platforms. The authority has urged the government to implement strict monitoring mechanisms to ensure compliance and prevent unauthorized products from reaching consumers.
The rise of e-commerce in Pakistan has made medicines more accessible, but it has also opened the door to unregulated and potentially harmful products. DRAP’s move is aimed at closing this gap by ensuring that online pharmacies operate under the same regulatory framework as traditional outlets.
Healthcare experts have welcomed the proposal, noting that unregistered medicines can lead to serious health complications, ineffective treatments, and even fatalities. They stress that regulation is essential to protect patients and maintain trust in the healthcare system.
DRAP’s recommendation also highlights the importance of consumer awareness. Patients are advised to purchase medicines only from licensed pharmacies and verify that products are registered with the authority.
By pushing for this ban, DRAP is reinforcing its commitment to public safety, accountability, and the integrity of Pakistan’s healthcare system. If implemented, the measure will mark a significant step toward regulating online medicine sales and ensuring that patients receive only safe, approved treatments.
+ There are no comments
Add yours